These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3747267)

  • 1. Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit.
    Tawara K; Ishihara M; Ogawa H; Tomikawa M
    Jpn J Pharmacol; 1986 Jun; 41(2):211-22. PubMed ID: 3747267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pantethine on lipoprotein profiles and HDL subfractions in experimentally hypercholesterolemic rabbits.
    Tomikawa M; Nakayasu T; Tawara K; Kameda KY; Abiko Y
    Atherosclerosis; 1982 Feb; 41(2-3):267-77. PubMed ID: 7066075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits.
    Carrara P; Matturri L; Galbussera M; Lovati MR; Franceschini G; Sirtori CR
    Atherosclerosis; 1984 Dec; 53(3):255-64. PubMed ID: 6442152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
    Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
    J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
    Tomikawa M; Nakayasu T; Tawara K; Abiko Y
    Atherosclerosis; 1981 Oct; 40(2):101-13. PubMed ID: 6946776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits.
    Ying H; Saku K; Harada R; Takami N; Sasaki N; Saito Y; Arakawa K
    Biochim Biophys Acta; 1990 Dec; 1047(3):247-54. PubMed ID: 2123720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
    Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M
    Artery; 1985; 12(4):234-43. PubMed ID: 3935096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of pravastatin and probucol on high-density lipoprotein apolipoprotein A-I kinetics in cholesterol-fed rabbits.
    Saku K; Liu R; Jimi S; Matsuo K; Yamamoto K; Yanagita T; Arakawa K
    Jpn Circ J; 1995 May; 59(5):292-8. PubMed ID: 7596034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of probucol administration on lipoprotein cholesterol and apolipoproteins in normolipemic males.
    Berg A; Frey I; Baumstark M; Keul J
    Atherosclerosis; 1988 Jul; 72(1):49-54. PubMed ID: 3214458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
    Hong SC; Zhao SP; Wu ZH
    Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro.
    Trezzi E; Roma P; Bernini F; Fumagalli R; Catapano AL
    Atherosclerosis; 1984 Sep; 52(3):309-16. PubMed ID: 6093829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels.
    Stein Y; Stein O; Delplanque B; Fesmire JD; Lee DM; Alaupovic P
    Atherosclerosis; 1989 Feb; 75(2-3):145-55. PubMed ID: 2712860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pantethine on in-vitro peroxidation of low density lipoproteins.
    Bon GB; Cazzolato G; Zago S; Avogaro P
    Atherosclerosis; 1985 Oct; 57(1):99-106. PubMed ID: 4074466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE; Schwenke DC; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term treatment with probucol on serum lipoproteins in cases of familial hypercholesterolemia in the elderly.
    Morisaki N; Mori S; Kobayashi J; Ishikawa Y; Shinomiya M; Shirai K; Saito Y; Yoshida S
    J Am Geriatr Soc; 1990 Jan; 38(1):15-8. PubMed ID: 2295765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
    Dachet C; Jacotot B; Buxtorf JC
    Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations.
    Schwenke DC; Behr SR
    Circ Res; 1998 Aug; 83(4):366-77. PubMed ID: 9721693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.